Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (325) Arrow Down
Filter Results: (325) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (1,344)
    • Faculty Publications  (325)

    Show Results For

    • All HBS Web  (1,344)
      • Faculty Publications  (325)

      multinational pharmaceutical companyRemove multinational pharmaceutical company →

      ← Page 13 of 325 Results →

      Are you looking for?

      →Search All HBS Web
      • July 2004 (Revised October 2018)
      • Case

      Opium and Entrepreneurship in the Nineteenth Century

      By: Geoffrey Jones, Elisabeth Koll and Alexis Gendron
      This case examines the role of Jardine Matheson, a trading company founded by two Scottish merchants, in the opium trade between India and China during the nineteenth century. The two Opium Wars fought between Western powers and China, which sought to stop opium... View Details
      Keywords: History; Globalized Economies and Regions; Ethnicity; Multinational Firms and Management; Groups and Teams; Trade; Social and Collaborative Networks; China; United Kingdom
      Citation
      Educators
      Purchase
      Related
      Jones, Geoffrey, Elisabeth Koll, and Alexis Gendron. "Opium and Entrepreneurship in the Nineteenth Century." Harvard Business School Case 805-010, July 2004. (Revised October 2018.)
      • June 2004
      • Case

      Aventis SA (A): Planning for a Merger

      By: Joshua D. Margolis and Carin-Isabel Knoop
      Eight executives at Hoechst and Rhone-Poulenc must make four crucial decisions on the eve of merging their companies to become Aventis--what would become the world's third largest pharmaceutical firm. In addition to formulating a vision and strategy, the two firms must... View Details
      Keywords: Problems and Challenges; Mergers and Acquisitions; Horizontal Integration; Organizational Design; Organizational Culture; Pharmaceutical Industry; United States
      Citation
      Educators
      Purchase
      Related
      Margolis, Joshua D., and Carin-Isabel Knoop. "Aventis SA (A): Planning for a Merger." Harvard Business School Case 404-003, June 2004.
      • June 2004
      • Case

      Aventis SA (B): A Company is Born

      By: Joshua D. Margolis and Carin-Isabel Knoop
      Supplements the (A) case. View Details
      Keywords: Problems and Challenges; Mergers and Acquisitions; Horizontal Integration; Organizational Design; Organizational Culture; Pharmaceutical Industry; United States
      Citation
      Educators
      Purchase
      Related
      Margolis, Joshua D., and Carin-Isabel Knoop. "Aventis SA (B): A Company is Born." Harvard Business School Case 404-108, June 2004.
      • June 2004 (Revised June 2006)
      • Supplement

      Vertex Pharmaceuticals: R&D Portfolio Management (A)

      By: Gary P. Pisano, Lee Fleming and Eli Strick
      Vertex Pharmaceuticals, Inc., a drug discovery company that recently decided to pursue a vertically integrated business model, chose to build up its clinical development and commercial capabilities and infrastructure. For the first time in its history, Vertex will... View Details
      Keywords: Research and Development; Investment Portfolio; Pharmaceutical Industry
      Citation
      Purchase
      Related
      Pisano, Gary P., Lee Fleming, and Eli Strick. "Vertex Pharmaceuticals: R&D Portfolio Management (A)." Harvard Business School Supplement 604-101, June 2004. (Revised June 2006.)
      • March 2004 (Revised May 2005)
      • Case

      Foreign Exchange Hedging Strategies at General Motors

      By: Mihir A. Desai and Mark Veblen
      How should a multinational firm manage foreign exchange exposures? Examines transactional, translational, and competitive exposures. Describes General Motors' corporate hedging policies, its risk management structure, and how accounting rules impact hedging decisions.... View Details
      Keywords: Risk Management; Multinational Firms and Management; Currency Exchange Rate; Investment; Financial Markets; Manufacturing Industry; Auto Industry; Argentina; Japan; Canada; United States
      Citation
      Educators
      Purchase
      Related
      Desai, Mihir A., and Mark Veblen. "Foreign Exchange Hedging Strategies at General Motors." Harvard Business School Case 204-024, March 2004. (Revised May 2005.)
      • August 2003 (Revised January 2013)
      • Case

      Multinational Corporations in Apartheid-era South Africa: The Issue of Reparations

      By: Geoffrey Jones and Cate Reavis
      Considers the lawsuits filed on behalf of victims of apartheid against multinationals who operated in South Africa prior to 1994. Reviews the debates about divestment from and sanctions against South Africa from the 1950s. Includes case studies of companies that... View Details
      Keywords: Ethics; Multinational Firms and Management; Government Legislation; Lawsuits and Litigation; Business and Government Relations; Prejudice and Bias; South Africa
      Citation
      Educators
      Purchase
      Related
      Jones, Geoffrey, and Cate Reavis. "Multinational Corporations in Apartheid-era South Africa: The Issue of Reparations." Harvard Business School Case 804-027, August 2003. (Revised January 2013.)
      • June 2003 (Revised May 2006)
      • Case

      Cipla

      By: Rohit Deshpande and Laura Winig
      The head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line... View Details
      Keywords: Trade; Price; Global Strategy; Health Care and Treatment; Patents; Leadership; Marketing Strategy; Health Industry; South Africa; India
      Citation
      Educators
      Purchase
      Related
      Deshpande, Rohit, and Laura Winig. "Cipla." Harvard Business School Case 503-085, June 2003. (Revised May 2006.)
      • February 2003 (Revised August 2005)
      • Case

      UCB (A): Managing Information for Globalization and Innovation

      By: F. Warren McFarlan and Brian DeLacey
      This case presents a complex total MIS strategy case for a $3 billion European pharmaceutical/chemicals company based in Brussels. It covers corporate strategy alignment of IT portfolio, IT operations issues, and global coordination of IT. View Details
      Keywords: Information Technology; Operations; System; Corporate Strategy; Investment Portfolio; Globalization; Pharmaceutical Industry; Pharmaceutical Industry; Brussels
      Citation
      Educators
      Purchase
      Related
      McFarlan, F. Warren, and Brian DeLacey. "UCB (A): Managing Information for Globalization and Innovation." Harvard Business School Case 303-091, February 2003. (Revised August 2005.)
      • January 2003 (Revised June 2005)
      • Case

      Multinationals as Engines of Growth?

      By: Geoffrey G. Jones
      Reviews the issues surrounding estimating the impact over time of multinationals on host economies. Uses a series of short historical case studies, including the role of United Fruit in the "banana" republics of Central America, oil and banking in Iran before the... View Details
      Keywords: Business History; Multinational Firms and Management; Trade; Growth and Development; Corporate Entrepreneurship; Globalized Economies and Regions; Iran; United States; Malaysia; Japan
      Citation
      Find at Harvard
      Related
      Jones, Geoffrey G. "Multinationals as Engines of Growth?" Harvard Business School Case 803-108, January 2003. (Revised June 2005.)
      • October 2002
      • Teaching Note

      Strategy in Emerging Markets (TN)

      By: Tarun Khanna
      Provides an overview of several cases on multinational and local companies (including business groups) operating in settings in Asia, Africa, Latin America, and worldwide. Also provides a conceptual framework for thinking about these cases and links to related academic... View Details
      Keywords: Framework; Global Range; Local Range; Globalized Firms and Management; Body of Literature; Emerging Markets; Africa; Asia; Latin America
      Citation
      Purchase
      Related
      Khanna, Tarun. "Strategy in Emerging Markets (TN)." Harvard Business School Teaching Note 703-430, October 2002.
      • Article

      Control, Performance, and Knowledge Transfers in Large Multinationals: Unilever in the United States, 1945-1980

      By: G. Jones
      This article considers key issues relating to the organization and performance of large multinational firms in the post-Second World War period. Although foreign direct investment is defined by ownership and control, in practice the nature of that "control" is far from... View Details
      Keywords: Multinational Firms and Management; Governance Controls; Performance; Business or Company Management; Ownership; Consumer Products Industry; Manufacturing Industry; United States
      Citation
      Find at Harvard
      Related
      Jones, G. "Control, Performance, and Knowledge Transfers in Large Multinationals: Unilever in the United States, 1945-1980." Business History Review 76, no. 3 (Fall 2002): 435–478.
      • June 2002 (Revised November 2005)
      • Case

      Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa

      By: Debora L. Spar
      In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details
      Keywords: Patents; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa
      Citation
      Educators
      Purchase
      Related
      Spar, Debora L., and Nick Bartlett. "Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa." Harvard Business School Case 702-049, June 2002. (Revised November 2005.)
      • March 2002 (Revised October 2005)
      • Case

      Wal-Mart in 2002

      By: David B. Yoffie and Yusi Wang
      In its first quarter of 2002, Wal-Mart became the largest company on the globe (by sales) and expanded into Japan. Was the giant retailer unstoppable? This case explores Wal-Mart's top issues in fueling top- and bottom-line growth: diversification into groceries, new... View Details
      Keywords: Diversification; Expansion; Multinational Firms and Management; Corporate Strategy; Global Strategy; Retail Industry; Japan; United States
      Citation
      Educators
      Purchase
      Related
      Yoffie, David B., and Yusi Wang. "Wal-Mart in 2002." Harvard Business School Case 702-466, March 2002. (Revised October 2005.)
      • February 2002
      • Case

      Fighting AIDS and Pricing Drugs

      By: John T. Gourville
      In early 2001, makers of AIDS drugs were suing to prevent developing countries from violating their patents. The issue was driven by price. The developing countries could not afford the market price for these drugs. At the same time, the drug companies were reluctant... View Details
      Keywords: Developing Countries and Economies; Patents; Price; Strategy; Globalized Markets and Industries; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Gourville, John T. "Fighting AIDS and Pricing Drugs." Harvard Business School Case 502-061, February 2002.
      • January 2002
      • Case

      Noranda Inc.: Mining, Smelting, and Sustainability?

      By: Richard H.K. Vietor
      Noranda is a $7 billion international mining and smelting company headquartered in Canada. It has been cited for its fine environmental record. This case explores the issue of sustainability--in this case, for a mining company. Over time, and under nongovernmental... View Details
      Keywords: Cost vs Benefits; Mining; Cost Management; Multinational Firms and Management; Governing Rules, Regulations, and Reforms; Policy; Environmental Sustainability; Mining Industry
      Citation
      Educators
      Purchase
      Related
      Vietor, Richard H.K. "Noranda Inc.: Mining, Smelting, and Sustainability?" Harvard Business School Case 702-009, January 2002.
      • December 2001 (Revised January 2002)
      • Case

      Nestle S.A.

      By: Ray A. Goldberg and Hal Hogan
      Peter Brabeck wants to focus Nestle as a wellness company in the global food system and do so in a way that provides both growth in sales and margins in both developed and developing countries. View Details
      Keywords: Brands and Branding; Product Development; Supply Chain Management; Food; Multinational Firms and Management; Business Growth and Maturation; Sales; Agriculture and Agribusiness Industry; Food and Beverage Industry; Switzerland
      Citation
      Educators
      Purchase
      Related
      Goldberg, Ray A., and Hal Hogan. "Nestle S.A." Harvard Business School Case 902-419, December 2001. (Revised January 2002.)
      • September 2001 (Revised July 2009)
      • Case

      Buenos Aires Embotelladora S.A. (BAESA): A South American Restructuring

      By: Stuart C. Gilson and Gustavo A. Herrero
      In 1998, BAESA, PepsiCo's largest bottler and distributor outside North America, experienced severe financial difficulty and had to restructure its debt and business operations to avoid bankruptcy or liquidation. Based in Argentina, with operations throughout South... View Details
      Keywords: Restructuring; Borrowing and Debt; Insolvency and Bankruptcy; Bonds; Stocks; Multinational Firms and Management; Laws and Statutes; United States; Argentina; Brazil
      Citation
      Educators
      Purchase
      Related
      Gilson, Stuart C., and Gustavo A. Herrero. "Buenos Aires Embotelladora S.A. (BAESA): A South American Restructuring." Harvard Business School Case 202-009, September 2001. (Revised July 2009.)
      • 2001
      • Book

      Foreign Multinationals in the United States: Management and Performance

      By: Geoffrey Jones and Lina Galvez-Munoz
      In this volume, leading scholars in international business and business history examine the investments and performance of British, Canadian, French, German, Spanish and Japanese firms in the United States over time. They explore why so many foreign firms experience... View Details
      Keywords: Investment; Multinational Firms and Management; Books; Management; Performance; Perspective; United States
      Citation
      Find at Harvard
      Purchase
      Related
      Jones, Geoffrey, and Lina Galvez-Munoz, eds. Foreign Multinationals in the United States: Management and Performance. London: Routledge, 2001.
      • August 2001 (Revised March 2008)
      • Case

      Helios Health (A)

      By: Regina E. Herzlinger and Alfred Martin
      Helios PC system provides personalized drug information to the patients in the doctor's waiting room. It has met with considerable consumer acceptance and a very high return for the drug companies that sponsor it. What price should it charge them for the service? View Details
      Keywords: Entrepreneurship; Price; Health Care and Treatment; Information Publishing; Innovation and Invention; Product Marketing; Demand and Consumers; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Find at Harvard
      Related
      Herzlinger, Regina E., and Alfred Martin. "Helios Health (A)." Harvard Business School Case 302-022, August 2001. (Revised March 2008.)
      • July 2001 (Revised August 2005)
      • Case

      Medicines Company, The

      By: John T. Gourville
      It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The... View Details
      Keywords: Business Model; Change Management; Decision Choices and Conditions; Cost Management; Price; Product Marketing; Product Launch; Product Development; Risk and Uncertainty; Pharmaceutical Industry; Pharmaceutical Industry
      Citation
      Educators
      Purchase
      Related
      Gourville, John T. "Medicines Company, The." Harvard Business School Case 502-006, July 2001. (Revised August 2005.)
      • ←
      • 13
      • 14
      • 15
      • 16
      • 17
      • →

      Are you looking for?

      →Search All HBS Web
      ǁ
      Campus Map
      Harvard Business School
      Soldiers Field
      Boston, MA 02163
      →Map & Directions
      →More Contact Information
      • Make a Gift
      • Site Map
      • Jobs
      • Harvard University
      • Trademarks
      • Policies
      • Accessibility
      • Digital Accessibility
      Copyright © President & Fellows of Harvard College.